Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice-Reference-Cited by-同舟云学术

Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice

Published:2010-05-17 Issue:22 Volume:107 Page:10190-10195
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Kakoki M.,Sullivan K. A.,Backus C.,Hayes J. M.,Oh S. S.,Hua K.,Gasim A. M. H.,Tomita H.,Grant R.,Nossov S. B.,Kim H.-S.,Jennette J. C.,Feldman E. L.,Smithies O.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference56 articles.

1. The Broad Substrate Specificity of Human Angiotensin I Converting Enzyme

2. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.

3. Importance of quantitative genetic variations in the etiology of hypertension

4. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

5. Angiotensin-Converting Enzyme Gene Polymorphism Has No Influence on the Circulating Renin-Angiotensin-Aldosterone System or Blood Pressure in Normotensive Subjects

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinin receptors regulate skeletal muscle regeneration: differential effects for B1 and B2 receptors;Inflammation Research;2023-07-18

2. Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy;Molecular Biology Reports;2023-07-17

3. Role of Inflammation in Progression of Chronic Kidney Disease in Type 2 Diabetes Mellitus: Clinical Implications;Seminars in Nephrology;2023-05

4. Mouse models of type 1 diabetes and their use in skeletal research;Current Opinion in Endocrinology, Diabetes & Obesity;2022-06-24

5. Podocyte VEGF-A Knockdown Induces Diffuse Glomerulosclerosis in Diabetic and in eNOS Knockout Mice;Frontiers in Pharmacology;2022-02-23